Intrauterine levobupivacaine for pain control during intrauterine device insertion

Authors

  • Nilufer Akgun Department of Obstetrics and Gynecology, Turgut Ozal University, Ankara, Turkey
  • Esra Keskin Department of Obstetrics and Gynecology, Turgut Ozal University, Ankara, Turkey
  • Muberra Namlı Kalem Department of Obstetrics and Gynecology, Turgut Ozal University, Ankara, Turkey
  • Batuhan Bakirarar Department of Biostatistics, Ankara University, Faculty of Medicine, Ankara, Turkey

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20170596

Keywords:

IUD, Levobupivacaine, Pain

Abstract

Background: Safe, effective, long term and a reversible contraception method is offered by intrauterine devices (IUDs).  The objective was to determine the potency of intrauterine administration of 5 cc levobupivacain for pain relief with IUD insertion, when compared with saline placebo.

Methods: This was a prospective randomized, double blind placebo-controlled trial undergoing İUD insertion. The trial medication was intrauterine anesthesia, either 5 mL 0.9% saline (control group), or 5 mL 0.5% levobupivacaine. Our primary outcome was self-reported pain scores on a 10 cm visual analogue scale (VAS) immediately following IUD insertion.

Results: 95 women were enrolled, and data for 88 women were analyzed. In IUD insertion procedure, no difference was observed between groups during teneculum placement and solution administration, in the course of VAS scores (p=0.349, p=0.396). There was a significant difference in the VAS scores measuring pain suffering during and after IUD procedure (p=0.001).

Conclusions: Intrauterine instillation of 5 cc of levobupivacaine along with saline solution reduces pain with IUD insertion when compared to intrauterine saline placebo. Broad deviation in pain scores and persistent pain after IUD insertion recommends that patient would benefit from more functioning method of pain control than before at IUD insertion and during the post interval.

References

Peipert JF, Zhao Q, Allsworth JE. Continuation and satisfaction of reversible contraception. Obstet Gynecol. 2012;117:1105-13.

Goldstuck ND. Pain reduction during and after insertion of an intrauterine contraceptive device. Adv Contracept. 1987;3:25-36.

Cırık DA, Taşkın EA, Tuğlu A, Ortaç A S, Dai Ö. Paracervical block with 1% lidocaine for pain control during intrauterine device insertion: A prospective, single-blinded, controlled study. Int J Reprod Contracept Obstet Gynecol. 2013;2:263-7.

Rubin SE, Winrob I. Urban female family medicine patients' perceptions about intrauterine contraception. J Women Health (Larchmt). 2010;19:735-40.

Maguire K, Davis A, Rosario Tejeda L. Intracervical lidocaine gel for intrauterine device insertion: a randomized controlled trial. Contraception 2012;86:214-9.

Chor J, Bregand-White J, Golobof A, Harwood B, Cowett A. Ibuprofen prophylaxis for levonorgestrel-releasing intrauterine system insertion: a randomized controlled trial. Contraception. 2011;85:558-62.

Dijkhuizen K, Dekkers OM, Holleboom CA, Groot de CJ, Hellebrekers BW, van Roosmalen GJ, et al. Vaginal misoprostol prior to insertion of an intrauterine device: an RCT. Hum Reprod. 2011;26:323-9.

Oloto E, Bromham D, Murty J. Pain and discomfort perception at IUD insertion-effect of short-duration, low-volume, intracervical application of two percent lignocain gel (Instillagel)-a preliminary study. Br J Fam Plann. 1996;22:177-80.

Mody SK, Kiley J, Rademaker A, Gawron L, Stika C, Hammond C. Pain control for intrauterine device insertion: a randomized trial of 1% lidocaine paracervical block. Contraception. 2012;86(6):704-9.

Costello MF, Horrowitz S, Steigrad S, Saif N, Bennett M, Ekangaki A. Transcervical intrauterine topical local anesthetic at hysterosalpingography: a prospective, randomized, double-blind, placebo-controlled trial. Fertility sterility. 2002;78(5):1116-22.

Tornblom-Paulander S, Tingaker BK, Werner A, Liliecreutz C, Conner P, Wessel H, Ekman-Ordeberg, G. Novel topical formulation of lidocaine provides significant pain relief for intrauterine device insertion: pharmacokinetic evaluation and randomized placebo-controlled trial. Fertility sterility. 2015;103(2):422-7.

Bijur PE, Silver W, Gallagher EJ. Reliability of the visual analog scale for measurement of acute pain. Acad emer med. 2001;8(12):1153-7.

Maguire K, Morrell K, Westhoff C, Davis A. Accuracy of providers' assessment of pain during intrauterine device insertion. Contraception. 2014;89(1):22-4.

Nelsona AL, Fong JK. Intrauterine infusion of lidocaine does not reduce pain scores during IUD insertion. Contraception. 2013;88:37-40.

Trolice MP, Fishburne C Jr, McGrady S. Anesthetic efficacy of intrauterine lidocaine for endometrial biopsy: a randomized double‐masked trial. Obstet Gynecol. 2000; 95:3, 345-7.

Dogan E, Celiloglu M, Sarihan E, Demir A. Anesthetic effect of intrauterine lidocaine plus naproxen sodium in endometrial biopsy. Obstet Gynecol. 2004;103:347-51.

Hubacher D, Reyes V, Lillo S, Zepeda A, Chen PL, Croxatto H. Painfrom copper intrauterine device insertion: randomized trial of prophylactic ibuprofen. Am J Obstet Gynecol. 2006;195:1272-7.

Sanford M, Keating GM. Levobupivacaine. Drugs. 2010;70(6)761-91.

Danielsson GK, Mansour D, Fiala C, Kaunitz AM, Bahamondes L. Management of pain associated with the insertion of intrauterine contraceptives. Hum Reprod Update. 2013, dmt022. May 12 [epub ahead of print].

Lopez LM, Bernholc A, Zeng Y, Allen R H, Bartz D, O'Brien PA, Hubacher D. Interventions for pain with intrauterine device insertion. The Cochrane Library. Cochrane Database of Systematic Reviews. 2015;7: CD007373

Karabayirli S, Ayrım AA, Muslu B. Comparison of the analgesic effects of oral tramadol and naproxen sodium on pain relief during IUD insertion. J Minimally invasive gynecol. 2012;19(5)581-4.

Maguire K, Davis A, Tejeda LR, Westhoff C. Intracervical lidocaine gel for intrauterine device insertion: a randomized controlled trial. Contraception. 2012;86(3,) 214-9.

McNicholas CP, Madden T, Zhao Q, Secura G, Allsworth JE, Peipert JF. Cervical lidocaine for IUD insertional pain: a randomized controlled trial. Am J Obstet Gynecol. 2012;207(5):384-e1.

Paulander TS, Tingaker BK, Werner A, Liliecreutz C, Conner P, Wessel H, Ordeberg EG. Novel topical formulation of lidocaine provides significant pain relief for intrauterine device insertion: pharmacokinetic evaluation and randomized placebo-controlled trial. Fertility Sterility. 2015;103(2)422-7.

Aksoy H, Aksoy U, Ozyurt S, Acmaz G, Babayigit M. Lidocaine 10% spray to the cervix reduces pain during intrauterine device insertion: a double-blind randomised controlled trial. J Fam Planning Reprod Health Care. 2016;42(2):83-7.

Tavakolian S, Doulabi MA, Baghban AA, Mortazavi A, Ghorbani M. Lidocaine-prilocaine cream as analgesia for IUD insertion: a prospective, randomized, controlled, triple blinded study. Global J Health Sci. 2015;7(4)399.

Allen RH, Bartz D, Grimes DA, Hubacher D, O'Brien P. Interventions for pain with intrauterine device insertion. The Cochrane Library. 2009;8(3):CD007373

Burlacu CL, Buggy DJ. Update on local anesthetics: focus on levobupivacaine. Therapeutics Clin Risk Management. 2008;4(2)381.

Downloads

Published

2017-02-19

Issue

Section

Original Research Articles